Buscar resultados de ensayos clínicos
Gastro-enteropancreatic Neuroendocrine Tumor - 19 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET Condición: Gastroenteropancreatic Neuroendocrine Tumors Fecha: 2014-09-02 Intervenciones:
|
Completed |
Nombre del estudio: 68Ga-OPS202 Study for Diagnostic Imaging of GEP NET Condición: Gastroenteropancreatic Neuroendocrine Tumors Fecha: 2014-06-03 Intervenciones: Drug: 68Ga-OPS202 |
Recruiting |
Nombre del estudio: 177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs Condición: Gastroenteropancreatic Neuroendocrine Tumors Fecha: 2013-04-25 Intervenciones: Drug: Intravenous injection of 177Lu-octreotate Treatment will consist of 177Lu-octreotate injections in |
Completed |
Nombre del estudio: Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs Condición: Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System Fecha: 2010-12-16 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors Condición:
|
Recruiting |
Nombre del estudio: Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors Condición:
|
Active, not recruiting |
Nombre del estudio: The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases Condición:
|
Recruiting |
Nombre del estudio: FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas Condición:
|
Enrolling by invitation |
Nombre del estudio: Gastroenteral-Pancreatic Neuroendocrine Tumors in Taiwan Condición: This Study Plans to Include 600 GEP-NET Patients. Fecha: 2014-02-27 |